Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.98
Delayed Data
As of Feb 17
 -0.17 / -2.09%
Today’s Change
5.77
Today|||52-Week Range
9.88
-6.88%
Year-to-Date

Today’s Trading

Previous close8.15
Today’s open8.15
Day’s range7.94 - 8.16
Volume282,308
Average volume (3 months)295,435
Market cap$626.5M
Dividend yield--
Data as of 3:59pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+126.67%
Earnings growth (next 5 years)+27.50%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book2.89

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.12+1.22%
PTIProteostasis Therape...+0.38+2.39%
FMIFoundation Medicine ...+0.55+2.31%
NVTAInvitae Corp-0.07-0.73%
Data as of 4:02pm ET, 02/17/2017

Financials

Next reporting dateFebruary 22, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts


Search for Jobs